All tissues tested were negative for p16, the cell cycle protein that is upregulated in HPV+ HNSCC, lost in the first steps of malignant progression in HPV– HNSCC (34), and used as a surrogate biomarker for HPV status in oropharynx HNSCC. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.